≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat
    ≥99% Purity Verified by Third-Party Labs
    Free Shipping on Orders Over $100
    HPLC & Mass Spec 2X Tested
    Same Day Shipping on Orders Before 2PM EST Mon-Sat

    Research use only · Not for human or veterinary use

    HMG research peptide - high purity lyophilized powder for laboratory research

    75IU

    $55
    3ml Vial
    Sold Out

    This product is for research purposes only. Not for human consumption.

    Purity: >98% (HPLC verified)

    Formulation: Lyophilized powder

    Molecular Formula: N/A (Glycoprotein complex)

    Molecular Weight: ~30,000-40,000 g/mol

    CAS Number: 61489-71-2

    PubChem CID: N/A

    HMG

    Reproductive

    Overview

    In laboratory research, HMG is used to study the effects of exogenous FSH and LH. For example, it is used in models of controlled ovarian stimulation to induce the development of multiple ovarian follicles, in contrast to the single dominant follicle that typically develops in a natural cycle. Its use has been explored in animal models of hypogonadotropic hypogonadism, a state characterized by insufficient endogenous gonadotropin stimulation.

    In contrast to recombinant FSH (rFSH) preparations, which contain only FSH, HMG contains both FSH and LH activity. This compositional difference is a variable that has been explored in comparative laboratory studies.

    Mechanism of Action

    HMG contains follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which exert their actions by binding to their respective G-protein coupled receptors on gonadal cells.

    FSH Receptor Signaling

    FSH binds to its receptor (FSHR), primarily found on granulosa cells in the ovary and Sertoli cells in the testes. This binding activates a Gs-mediated signaling cascade involving adenylyl cyclase, increased cyclic AMP (cAMP), and activation of protein kinase A (PKA). This pathway influences gene transcription through factors such as CREB.

    In ovarian granulosa cells, FSH stimulation promotes cell proliferation, follicle growth, and expression of the aromatase enzyme, which is responsible for converting androgens to estrogens. FSH also upregulates LH receptor expression on granulosa cells.

    Follicle Development

    In a typical reproductive cycle, only one dominant follicle continues to develop while others undergo atresia. The presence of sufficient FSH is important for follicle survival. In experimental models of ovarian stimulation using exogenous gonadotropins like HMG, the elevated levels of FSH can prevent atresia, allowing multiple follicles to continue their growth and maturation simultaneously.

    LH Receptor Signaling

    LH binds to the LH/choriogonadotropin receptor (LHCGR) on ovarian theca cells and testicular Leydig cells. In female models, LH stimulation of theca cells leads to the production of androgens, which serve as precursors for estrogen synthesis in granulosa cells. A surge in LH levels is a key event that leads to final oocyte maturation, ovulation, and luteinization of the follicle into the corpus luteum.

    Male Reproductive System

    In males, LH stimulates Leydig cells to synthesize testosterone. FSH acts on Sertoli cells, which support the development of sperm cells. The presence of both FSH and high intratesticular testosterone is integral to the process of spermatogenesis.

    Research Findings

    Published nonclinical literature relevant to this material's molecular targets and experimental models is listed below for independent review. Findings involving other preparations or experimental systems should not be attributed to this research material.

    Research Applications

    • Gonadotropin physiology and receptor biology
    • Reproductive endocrinology research
    • Controlled ovarian stimulation models
    • Ovulation induction studies
    • Spermatogenesis research
    • Hypogonadotropic hypogonadism models
    • Comparative gonadotropin studies
    • Ovarian Hyperstimulation Syndrome (OHSS) models
    • Studies on ovarian reserve markers

    Laboratory Handling & Limitations

    This material is supplied solely for in vitro and other nonclinical laboratory research. It is not for human or veterinary use, consumption, administration, therapeutic use, or diagnostic use.

    Laboratory Handling

    Handle only in an appropriately equipped laboratory using applicable institutional procedures, personal protective equipment, and the storage conditions shown for the material. The purchaser is responsible for study design, handling controls, disposal, and regulatory compliance.

    Research Limitations

    Published observations involving other preparations, experimental systems, or study populations do not establish the identity, performance, or suitability of this research material for any particular experiment.

    Scientific References

    1. Filicori, M., et al. (2005). Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility, 84(2), 394-401.
    2. Liu, P. Y., et al. (2009). Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis. Fertility and Sterility, 92(6), 2144-2149.

    Research Use Only

    This product is intended for research purposes only and is not for human consumption, therapeutic use, or diagnostic applications. Please ensure compliance with all applicable regulations and institutional guidelines.